1887

Abstract

A total of 188 human ( = 92) and animal ( = 96) isolates of of different PCR ribotypes were screened for susceptibility to 30 antimicrobials using broth microdilution. When comparing the prevalence of antimicrobial resistance, the isolates of animal origin were significantly more often resistant to oxacillin, gentamicin and trimethoprim/sulfamethoxazole (<0.01). The most significant difference between the animal and human populations ( = 0.0006) was found in the level of imipenem resistance, with a prevalence of 53.3 % in isolates of human origin and 28.1 % in isolates of animal origin. Overall, the results show similar MICs for the majority of tested antimicrobials for isolates from human and animal sources, which were collected from the same geographical region and in the same time interval. This supports the hypothesis that could be transmissible between human and animal hosts. Resistant isolates have been found in all animal species tested, including food and companion animals, and also among non-toxigenic isolates. The isolates of the most prevalent PCR ribotype 014/020 had low resistance rates for moxifloxacin, erythromycin, rifampicin and daptomycin, but a high resistance rate for imipenem. Multiresistant strains were found in animals and humans, belonging to PCR ribotypes 012, 017, 027, 045, 046, 078 and 150, and also to non-toxigenic strains of PCR ribotypes 010 and SLO 080.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.058875-0
2013-09-01
2024-12-09
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/9/1478.html?itemId=/content/journal/jmm/10.1099/jmm.0.058875-0&mimeType=html&fmt=ahah

References

  1. Ackermann G., Degner A., Cohen S. H., Silva J. Jr, Rodloff A. C. 2003; Prevalence and association of macrolide-lincosamide-streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile.. J Antimicrob Chemother 51:599–603 [View Article][PubMed]
    [Google Scholar]
  2. Alvarez-Perez S., Blanco J. L., Bouza E., Alba P., Gibert X., Maldonado J., Garcia M. E. 2009; Prevalence of Clostridium difficile in diarrhoeic and non-diarrhoeic piglets. Vet Microbiol 137:302–305 [View Article][PubMed]
    [Google Scholar]
  3. Avbersek J., Janezic S., Pate M., Rupnik M., Zidaric V., Logar K., Vengust M., Zemljic M., Pirs T., Ocepek M. 2009; Diversity of Clostridium difficile in pigs and other animals in Slovenia. Anaerobe 15:252–255 [View Article][PubMed]
    [Google Scholar]
  4. Bakker D., Corver J., Harmanus C., Goorhuis A., Keessen E. C., Fawley W. N., Wilcox M. H., Kuijper E. J. 2010; Relatedness of human and animal Clostridium difficile PCR ribotype 078 isolates determined on the basis of multilocus variable-number tandem-repeat analysis and tetracycline resistance. J Clin Microbiol 48:3744–3749 [View Article][PubMed]
    [Google Scholar]
  5. Barbut F., Mastrantonio P., Delmée M., Brazier J., Kuijper E., Poxton I.on behalf of the European Study Group on Clostridium difficile (ESGCD) 2007; Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13:1048–1057 [View Article][PubMed]
    [Google Scholar]
  6. Bartlett J. G. 1992; Antibiotic-associated diarrhea. Clin Infect Dis 15:573–581 [View Article][PubMed]
    [Google Scholar]
  7. Båverud V., Gustafsson A., Franklin A., Aspán A., Gunnarsson A. 2003; Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility. Equine Vet J 35:465–471 [View Article][PubMed]
    [Google Scholar]
  8. Båverud V., Gunnarsson A., Karlsson M., Franklin A. 2004; Antimicrobial susceptibility of equine and environmental isolates of Clostridium difficile.. Microb Drug Resist 10:57–63 [View Article][PubMed]
    [Google Scholar]
  9. CLSI 2012; Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard, M11-A8, 8th edn. Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  10. CLSI 2013; Performance Standards for Antimicrobial Susceptibility Testing; 23rd Informational Supplement M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  11. Curry S. R., Marsh J. W., Shutt K. A., Muto C. A., O’Leary M. M., Saul M. I., Pasculle A. W., Harrison L. H. 2009; High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital. Clin Infect Dis 48:425–429 [View Article][PubMed]
    [Google Scholar]
  12. ECDC 2013 Surveillance of Antimicrobial Consumption in Europe, 2010 Stockholm: European Centre for Disease Prevention and Control;
    [Google Scholar]
  13. EMA 2012; Sales of Veterinary Antimicrobial Agents in 19 EU/EEA Countries in 2010; EMA/88728/2012. London: European Medicines Agency;
    [Google Scholar]
  14. EUCAST 2013; Breakpoint Tables for Interpretation of MICs and Zone Diameters; version 3.0, 2013. http://www.eucast.org/clinical_breakpoints (accessed January 2013).Basel; European Committee on Antimicrobial Susceptibility Testing
    [Google Scholar]
  15. Fry P. R., Thakur S., Abley M., Gebreyes W. A. 2012; Antimicrobial resistance, toxinotype, and genotypic profiling of Clostridium difficile isolates of swine origin. J Clin Microbiol 50:2366–2372 [View Article][PubMed]
    [Google Scholar]
  16. Gould L. H., Limbago B. 2010; Clostridium difficile in food and domestic animals: a new foodborne pathogen?. Clin Infect Dis 51:577–582 [View Article][PubMed]
    [Google Scholar]
  17. Hammitt M. C., Bueschel D. M., Keel M. K., Glock R. D., Cuneo P., DeYoung D. W., Reggiardo C., Trinh H. T., Songer J. G. 2008; A possible role for Clostridium difficile in the etiology of calf enteritis. Vet Microbiol 127:343–352 [View Article][PubMed]
    [Google Scholar]
  18. Huang H., Weintraub A., Fang H., Nord C. E. 2009; Antimicrobial resistance in Clostridium difficile.. Int J Antimicrob Agents 34:516–522 [View Article][PubMed]
    [Google Scholar]
  19. Huang H., Weintraub A., Fang H., Wu S., Zhang Y., Nord C. E. 2010; Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains. Anaerobe 16:633–635 [View Article][PubMed]
    [Google Scholar]
  20. Janezic S., Ocepek M., Zidaric V., Rupnik M. 2012; Clostridium difficile genotypes other than ribotype 078 that are prevalent among human, animal and environmental isolates. BMC Microbiol 12:48 [View Article][PubMed]
    [Google Scholar]
  21. Keel K., Brazier J. S., Post K. W., Weese S., Songer J. G. 2007; Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol 45:1963–1964 [View Article][PubMed]
    [Google Scholar]
  22. Keessen E. C., Hensgens M. P. M., Spigaglia P., Barbanti F., Sanders I. M. J. G., Kuijper E. J., Lipman L. J. A. 2013; Antimicrobial susceptibility profiles of human and piglet Clostridium difficile PCR-ribotype 078. Antimicrob Resist Infect Control 2:14 [View Article][PubMed]
    [Google Scholar]
  23. Koene M. G. J., Mevius D., Wagenaar J. A., Harmanus C., Hensgens M. P. M., Meetsma A. M., Putirulan F. F., van Bergen M. A. P., Kuijper E. J. 2012; Clostridium difficile in Dutch animals: their presence, characteristics and similarities with human isolates. Clin Microbiol Infect 18:778–784 [View Article][PubMed]
    [Google Scholar]
  24. Kuijper E. J., Barbut F., Brazier J. S., Kleinkauf N., Eckmanns T., Lambert M. L., Drudy D., Fitzpatrick F., Wiuff C. other authors 2008; Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 13:18942[PubMed]
    [Google Scholar]
  25. Lefebvre S. L., Arroyo L. G., Weese J. S. 2006; Epidemic Clostridium difficile strain in hospital visitation dog. Emerg Infect Dis 12:1036–1037 [View Article][PubMed]
    [Google Scholar]
  26. Marks S. L., Kather E. J. 2003; Antimicrobial susceptibilities of canine Clostridium difficile and Clostridium perfringens isolates to commonly utilized antimicrobial drugs. Vet Microbiol 94:39–45 [View Article][PubMed]
    [Google Scholar]
  27. Muto C. A., Pokrywka M., Shutt K., Mendelsohn A. B., Nouri K., Posey K., Roberts T., Croyle K., Krystofiak S. other authors 2005; A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 26:273–280 [View Article][PubMed]
    [Google Scholar]
  28. Norén T., Alriksson I., Akerlund T., Burman L. G., Unemo M. 2010; In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden. Clin Microbiol Infect 16:1104–1110 [View Article][PubMed]
    [Google Scholar]
  29. Pirs T., Ocepek M., Rupnik M. 2008; Isolation of Clostridium difficile from food animals in Slovenia. J Med Microbiol 57:790–792 [View Article][PubMed]
    [Google Scholar]
  30. Post K. W., Songer J. G. 2004; Antimicrobial susceptibility of Clostridium difficile isolated from neonatal pigs with enteritis. Anaerobe 10:47–50 [View Article][PubMed]
    [Google Scholar]
  31. Rodriguez-Palacios A., Stämpfli H. R., Duffield T., Peregrine A. S., Trotz-Williams L. A., Arroyo L. G., Brazier J. S., Weese J. S. 2006; Clostridium difficile PCR ribotypes in calves, Canada. Emerg Infect Dis 12:1730–1736 [View Article][PubMed]
    [Google Scholar]
  32. Rupnik M., Wilcox M. H., Gerding D. N. 2009; Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7:526–536 [View Article][PubMed]
    [Google Scholar]
  33. Solomon K., Fanning S., McDermott S., Murray S., Scott L., Martin A., Skally M., Burns K., Kuijper E. other authors 2011; PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates. J Antimicrob Chemother 66:1976–1982 [View Article][PubMed]
    [Google Scholar]
  34. Songer J. G., Anderson M. A. 2006; Clostridium difficile: an important pathogen of food animals. Anaerobe 12:1–4 [View Article][PubMed]
    [Google Scholar]
  35. Spigaglia P., Barbanti F., Mastrantonio P., Brazier J. S., Barbut F., Delmée M., Kuijper E., Poxton I. R.on behalf of the European Study Group on Clostridium difficile (ESGCD) 2008; Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. J Med Microbiol 57:784–789 [View Article][PubMed]
    [Google Scholar]
  36. Spigaglia P., Barbanti F., Dionisi A. M., Mastrantonio P. 2010; Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018. J Clin Microbiol 48:2892–2896 [View Article][PubMed]
    [Google Scholar]
  37. Spigaglia P., Barbanti F., Mastrantonio P.on behalf of the European Study Group on Clostridium difficile (ESGCD) 2011; Multidrug resistance in European Clostridium difficile clinical isolates. J Antimicrob Chemother 66:2227–2234 [View Article][PubMed]
    [Google Scholar]
  38. Taori S. K., Hall V., Poxton I. R. 2010; Changes in antibiotic susceptibility and ribotypes in Clostridium difficile isolates from southern Scotland, 1979-2004. J Med Microbiol 59:338–344 [View Article][PubMed]
    [Google Scholar]
  39. Weese J. S. 2010; Clostridium difficile in food–innocent bystander or serious threat?. Clin Microbiol Infect 16:3–10 [View Article][PubMed]
    [Google Scholar]
  40. Weese J. S., Finley R., Reid-Smith R. R., Janecko N., Rousseau J. 2010; Evaluation of Clostridium difficile in dogs and the household environment. Epidemiol Infect 138:1100–1104 [View Article][PubMed]
    [Google Scholar]
  41. Zidaric V., Zemljic M., Janezic S., Kocuvan A., Rupnik M. 2008; High diversity of Clostridium difficile genotypes isolated from a single poultry farm producing replacement laying hens. Anaerobe 14:325–327 [View Article][PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.058875-0
Loading
/content/journal/jmm/10.1099/jmm.0.058875-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error